Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.130
-0.020 (-1.74%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Entera Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 53 | 89 | 78 | 17 | 21 | 81 | |
| Market Cap Growth | -31.37% | 13.93% | 351.66% | -17.80% | -74.05% | 308.59% | |
| Enterprise Value | 45 | 81 | 71 | 10 | 7 | 54 | |
| Last Close Price | 1.11 | 1.94 | 2.12 | 0.60 | 0.73 | 2.81 | |
| PS Ratio | 1232.16 | 2118.17 | 431.41 | - | 156.95 | 141.91 | |
| PB Ratio | 3.91 | 6.79 | 9.66 | 1.67 | 1.79 | 3.59 | |
| P/TBV Ratio | 3.95 | 6.79 | 9.66 | 1.67 | 1.79 | 3.59 | |
| EV/Sales Ratio | 1074.59 | 1919.05 | 394.91 | - | 51.05 | 94.51 | |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.03 | 0.04 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -0.50 | -0.50 | -1.04 | -1.02 | -1.04 | -1.09 | |
| Net Debt / EBITDA Ratio | 0.58 | 0.58 | 0.88 | 1.20 | 0.91 | 2.02 | |
| Net Debt / FCF Ratio | 0.89 | 0.89 | 1.23 | 1.45 | 0.97 | 2.71 | |
| Asset Turnover | 0.00 | 0.00 | 0.02 | - | 0.01 | 0.03 | |
| Quick Ratio | 3.33 | 3.33 | 7.47 | 10.10 | 9.36 | 7.93 | |
| Current Ratio | 6.94 | 6.94 | 7.63 | 10.32 | 9.58 | 8.01 | |
| Return on Equity (ROE) | -108.01% | -108.01% | -103.34% | -80.30% | -76.17% | -81.04% | |
| Return on Assets (ROA) | -56.77% | -56.77% | -56.64% | -44.65% | -43.06% | -42.77% | |
| Return on Capital Employed (ROCE) | -83.60% | -83.60% | -116.70% | -83.30% | -114.30% | -53.50% | |
| Earnings Yield | -22.10% | -12.86% | -12.22% | -51.42% | -62.15% | -15.04% | |
| FCF Yield | -14.45% | -8.40% | -8.73% | -42.38% | -59.65% | -11.21% | |
| Buyback Yield / Dilution | -22.68% | -22.68% | -29.79% | -0.69% | -10.23% | -41.90% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.